Open access · CC-BY
via OpenAlex
Novel Natural Deep Eutectic Solvent (NaDES) Yellow Choline Chloride and Molecular Docking Soybean Extract (Glycine max) as Diabetes Drugs Candidate
Rizky Yulion, Siti Hamidatul Aliyah, Santi Perawati, Lili Andriani, Putri Eryunita, Besek Arfiah, Anggito Surya Atmaja
Indonesian Journal of Chemical Studies · 2024 · ▲ 2 citations
Abstract
Natural Deep Eutectic Solvent (NaDES) is an environmentally friendly extraction method to obtain soybean bioactive compounds, focusing on genistein compounds as drug candidates. The use of environmentally friendly extraction solvents could support green extraction to ensure the safety of natural medicinal candidates. HBA (Hydrogen Bonding Acceptor), yellow choline chloride (supplement in animal feed), and HBD (Hydrogen Bonding Donor) lactic acid. A UV-Vis spectrophotometer was used to detect genistein. MoE 2022.02 software was used in the molecular docking simulation, and the docking scoring methods affinity ΔG and GBVI/WSA (induced fit) were used. The PDB ID used was: 5nn8 (alpha glucosidase) and PDB ID: 7vsi (SGLT-2 Inhibitor). The results of genistein were obtained by 92,670 mg (0.9267%) in the 75 0C, 30 min ultrasonic NaDES extraction in HBD lactic acid. Genistein exhibited an affinity for the 5NN8 (alpha-glucosidase) and 7VSI (SGLT-2 Inhibitor) receptors of -6,230 and -8,768, respectively. These affinity values did not exceed the interaction values of the native ligands acarbose (alpha-glucosidase) and Empagliflozin (SGLT-2 Inhibitor), which were -8,988 and -12,302, respectively. Genistein compounds had the lowest RMSD value of 0.819 at 7vsi (SGLT-2 Inhibitor). These results suggested the possibility of a genistein pathway as a candicate diabetes drug. The NaDES extraction method demonstrated great potential for development into a green action that supported the green extraction process, and genistein was an isoflavone compound that could be a candidate for diabetes drugs.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.55749/ijcs.v3i2.47
- Canonical
- link ↗
- Fetched
- 2026-11-09 MST
Cite this
APA
Yulion, R., Aliyah, S.H., Perawati, S., Andriani, L., Eryunita, P., Arfiah, B., & Atmaja, A.S. (2024). Novel Natural Deep Eutectic Solvent (NaDES) Yellow Choline Chloride and Molecular Docking Soybean Extract (Glycine max) as Diabetes Drugs Candidate. <em>Indonesian Journal of Chemical Studies</em>. https://doi.org/10.55749/ijcs.v3i2.47
Vancouver
Yulion R, Aliyah SH, Perawati S, Andriani L, Eryunita P, Arfiah B, et al. Novel Natural Deep Eutectic Solvent (NaDES) Yellow Choline Chloride and Molecular Docking Soybean Extract (Glycine max) as Diabetes Drugs Candidate. Indonesian Journal of Chemical Studies. 2024. doi:10.55749/ijcs.v3i2.47.
BibTeX
@article{rizky2024NovelN,
title = {Novel Natural Deep Eutectic Solvent (NaDES) Yellow Choline Chloride and Molecular Docking Soybean Extract (Glycine max) as Diabetes Drugs Candidate},
author = {Rizky Yulion and Siti Hamidatul Aliyah and Santi Perawati and Lili Andriani and Putri Eryunita and Besek Arfiah and Anggito Surya Atmaja},
journal = {Indonesian Journal of Chemical Studies},
year = {2024},
doi = {10.55749/ijcs.v3i2.47},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Brigham and Women's Hospital 2021
Open access · US-GOV
Prospective Monitoring of Angiotensin Receptor Neprilysin Inhibitor in Older Adults With Heart Failure and Frailty
Research Square 2025
Preprint · CC-BY
Design, synthesis of urolithin A, the metabolite of ellagitannins, and its biological activity of phosphodiesterase II (PDE2) inhibitors
Brigham and Women's Hospital 2021
Open access · US-GOV
Prospective Monitoring of Non-Vitamin K Oral Anticoagulants in Older Adults With Atrial Fibrillation and Frailty
Current Gene Therapy 2019
Preprint · CC-BY
Partial Reprogramming As An Emerging Strategy for Safe Induced Cell Generation and Rejuvenation
Frontiers in Cell and Developmental Biology 2021
Open access · CC-BY
Curculigoside Ameliorates Bone Loss by Influencing Mesenchymal Stem Cell Fate in Aging Mice
University of Rochester 2021
Open access · US-GOV